BACKGROUND: Recent evidence suggests that Rho-kinase (ROCK) plays an important role in the pathogenesis of atherosclerosis and a marker of atherosclerotic burden. Polyvascular disease with concomitant peripheral arterial disease (PAD) and coronary artery disease (CAD) is common and associated with a worse prognosis. The aim of this study was to evaluate ROCK activity as a marker of polyvascular disease. METHODS: We retrospectively analyzed patients undergoing coronary angiography at our institution between February 2009 and May 2009. Patients with only CAD (n = 40) defined by coronary artery stenosis of ≥50% by angiography, only PAD (n = 40) defined by an ankle brachial index (ABI) <0.9, and combined CAD/PAD (n = 40) were matched by age and sex to control patients (n = 40) without CAD or PAD. ROCK activity was determined by phosphorylation of the myosin binding subunit in leukocytes and then compared between each group. Multivariate analysis was used to determine independent predictors of polyvascular disease. Discriminative ability of elevated ROCK activity was assessed using receiver operator characteristics (ROC) curves. RESULTS: Patients (age 68 ± 12 years, 79% male) with CAD, PAD, and CAD/PAD had a mean ABI of 1.08, 0.62, and 0.65, respectively, compared to 1.08 in the control group. There was an incremental increase in ROCK activity in patients with CAD (4.61 ± 2.11), PAD (4.27 ± 1.39), and CAD/PAD (5.96 ± 1.94) compared to control (2.40 ± 0.43) (all P < 0.05). ROCK activity (odds ratio: 4.53, 95% confidence interval: 1.26-6.30) was an independent predictor of polyvascular disease. The ROCK cutoff value of 4.85 had a sensitivity of 72.7% and a specificity of 65.7%, with an area under ROC curve of 0.71 for polyvascular disease. CONCLUSIONS: Patients with concomitant peripheral and coronary arterial disease are associated with increased Rho-kinase activity. Rho-kinase activity may be a potential marker of atherosclerotic burden for patients with polyvascular disease.
BACKGROUND: Recent evidence suggests that Rho-kinase (ROCK) plays an important role in the pathogenesis of atherosclerosis and a marker of atherosclerotic burden. Polyvascular disease with concomitant peripheral arterial disease (PAD) and coronary artery disease (CAD) is common and associated with a worse prognosis. The aim of this study was to evaluate ROCK activity as a marker of polyvascular disease. METHODS: We retrospectively analyzed patients undergoing coronary angiography at our institution between February 2009 and May 2009. Patients with only CAD (n = 40) defined by coronary artery stenosis of ≥50% by angiography, only PAD (n = 40) defined by an ankle brachial index (ABI) <0.9, and combined CAD/PAD (n = 40) were matched by age and sex to control patients (n = 40) without CAD or PAD. ROCK activity was determined by phosphorylation of the myosin binding subunit in leukocytes and then compared between each group. Multivariate analysis was used to determine independent predictors of polyvascular disease. Discriminative ability of elevated ROCK activity was assessed using receiver operator characteristics (ROC) curves. RESULTS:Patients (age 68 ± 12 years, 79% male) with CAD, PAD, and CAD/PAD had a mean ABI of 1.08, 0.62, and 0.65, respectively, compared to 1.08 in the control group. There was an incremental increase in ROCK activity in patients with CAD (4.61 ± 2.11), PAD (4.27 ± 1.39), and CAD/PAD (5.96 ± 1.94) compared to control (2.40 ± 0.43) (all P < 0.05). ROCK activity (odds ratio: 4.53, 95% confidence interval: 1.26-6.30) was an independent predictor of polyvascular disease. The ROCK cutoff value of 4.85 had a sensitivity of 72.7% and a specificity of 65.7%, with an area under ROC curve of 0.71 for polyvascular disease. CONCLUSIONS:Patients with concomitant peripheral and coronary arterial disease are associated with increased Rho-kinase activity. Rho-kinase activity may be a potential marker of atherosclerotic burden for patients with polyvascular disease.
Authors: E Büssemaker; Frank Pistrosch; Sarah Förster; Kay Herbrig; Peter Gross; Jens Passauer; Ralf P Brandes Journal: Am J Physiol Heart Circ Physiol Date: 2007-03-23 Impact factor: 4.733
Authors: Ming Dong; Bryan P Yan; James K Liao; Yat-Yin Lam; Gabriel W K Yip; Cheuk-Man Yu Journal: Drug Discov Today Date: 2010-06-25 Impact factor: 7.851
Authors: Issam D Moussa; Michael R Jaff; Roxana Mehran; William Gray; George Dangas; Zoran Lazic; Jeffery W Moses Journal: Catheter Cardiovasc Interv Date: 2009-05-01 Impact factor: 2.692
Authors: Eric T Fung; Andrew M Wilson; Fujun Zhang; Nathan Harris; Kim A Edwards; Jeffrey W Olin; John P Cooke Journal: Vasc Med Date: 2008-08 Impact factor: 3.239
Authors: Steven K Feske; Farzaneh A Sorond; Galen V Henderson; Minoru Seto; Asako Hitomi; Koh Kawasaki; Yasuo Sasaki; Toshio Asano; James K Liao Journal: Brain Res Date: 2008-12-25 Impact factor: 3.252
Authors: Ana Paula Lucas Mota; Maria Elizabeth Rennó de Castro Santos; Francisco das Chagas Lima e Silva; Natália Castro de Carvalho Schachnik; Marinez de Oliveira Sousa; Maria das Graças Carvalho Journal: Angiology Date: 2008-11-17 Impact factor: 3.619
Authors: Anju Nohria; Adnan Prsic; Ping-Yen Liu; Ryuji Okamoto; Mark A Creager; Andrew Selwyn; James K Liao; Peter Ganz Journal: Atherosclerosis Date: 2008-12-24 Impact factor: 5.162
Authors: Nikola Sladojevic; Goo Taeg Oh; Hyung-Hwan Kim; Lea M Beaulieu; Hervé Falet; Karol Kaminski; Jane E Freedman; James K Liao Journal: Cardiovasc Res Date: 2017-09-01 Impact factor: 10.787